Article
Nucleotide sequence variation in the hypervariable region of the hepatitis C virus in the sera of chronic hepatitis C patients undergoing controlled interferon-alpha therapy.
Journal of medical virology - 1 Jun 1996
Yeh B I, Han K H, Oh S H, Kim H S, Hong S H, Oh S H, Kim Y S
Abstract excerpt
Ten patients with hepatitis C virus (HCV) infection (experimental group) were treated with interferon-alpha (IF-alpha). Dosage was six million units per day for one week and then three times a week for another six months. Seven HCV-infected patients (control group) did not receive IF-alpha therapy. The hypervariable region (HVR) of HCV in the sera of patients was amplified by reverse transcription-polymerase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
